Patricia Galván

6.5k citations
69 papers · 2.4k indexed · 2 hit papers · h-index 20
Topics
Advanced Breast Cancer Therapies (29 papers)Breast Cancer Treatment Studies (29 papers)HER2/EGFR in Cancer Research (27 papers)
Partner nations
SpainUnited StatesItaly

In The Last Decade

Patricia Galván

59 papers receiving 2.4k citations

Hit Papers

Clinical implications of the intrinsic molecular subtypes...201520262018202220152020250500750

Peers

Patricia Galván
Comparison fields: 5 of 100
  • Oncology 1.4k
  • Cancer Research 997
  • Molecular Biology 947
  • Pulmonary and Respiratory Medicine 671
  • Radiology, Nuclear Medicine and Imaging 263
Replace Marco Gerlinger with:
Marco Gerlinger United Kingdom
Coya Tapia Switzerland
Mónica V. Estrada United States
Yutaka Hatanaka Japan
Anne‐Vibeke Lænkholm Denmark
Laia Paré Spain
Pradip De United States
Mohammed A. Aleskandarany United Kingdom
Elin Borgen Norway
Dorthe Grabau Sweden
Patricia Galván relative to Marco Gerlinger United Kingdom Marco Gerlinger's profile →
Citations per field
00.5×1.5×2.1×
Marco Gerlinger · 1×
Citations per year

Countries citing papers authored by Patricia Galván

Since Specialization
Citations

This map shows the geographic impact of Patricia Galván's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patricia Galván with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patricia Galván more than expected).

Fields of papers citing papers by Patricia Galván

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patricia Galván. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patricia Galván. The network helps show where Patricia Galván may publish in the future.

Co-authorship network of co-authors of Patricia Galván

This figure shows the co-authorship network connecting the top 25 collaborators of Patricia Galván. A scholar is included among the top collaborators of Patricia Galván based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patricia Galván. Patricia Galván is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 4
3 5
4 1
5 0
6 1
7 12
8 8
9 5
10 0
11 0
12 0
13 1
14 19
15 277
16 64
17
Clinical implications of the intrinsic molecular subtypes of breast cancerbreakdown →
751
18 35
19 51
20 33

About Patricia Galván

Patricia Galván is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 69 papers that have together received 2.4k indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (29 papers), Breast Cancer Treatment Studies (29 papers) and HER2/EGFR in Cancer Research (27 papers). The work is most often cited by research in Cancer Research (997 citations), Oncology (1.4k citations) and Pulmonary and Respiratory Medicine (671 citations). Patricia Galván has collaborated with scholars based in Spain, United States and Italy. Frequent co-authors include Aleix Prat, Montserrat Muñoz-Mateu, Bárbara Adamo, Lydia Gaba, Ana Arance, Aranzazu Fernández-Martínez, Estela Pineda, Marc Díez, Margarita Viladot and Laia Paré. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026